EUVIMEDEUVIMED entdecken
Multizentrische Studie

Dermatological adverse effects of doxycycline as post-exposure prophylaxis for sexually transmitted infections among men who have sex with men: real-world findings from a multicentre study

Ling-Ya Chen iD, Wei-Ting Lin, Yi-Ting Chen, Po-Hsien Kuo iD, Wang-Da Liu, Yu-Shan Huang iD, Hsin-Yun Sun, Aristine Cheng, Yu-Zhen Luo, Pei-Ying Wu, Hsi-Yen Chang, Kuan-Yin Lin iD und 1 weitere

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkaf351 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Ling-Ya Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infection Control, National Taiwan University Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Doxycycline, Sexually Transmitted Diseases, Homosexuality, Male, Post-Exposure Prophylaxis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Taiwan Centers for Disease Control.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Doxycycline has demonstrated a favourable safety profile in clinical trials of post-exposure prophylaxis (doxy-PEP) for sexually transmitted infections; however, potential adverse effects may limit its feasibility. We aimed to investigate dermatological adverse effects of doxy-PEP in real-world settings.

Methods

This multicentre retrospective cohort study was conducted between October 2023 and February 2025, following the implementation of doxy-PEP among MSM. Individuals were encouraged to report adverse effects after initiating doxy-PEP. Data on medical history, previous therapeutic doxycycline exposure and history of allergic reactions were collected from electronic medical records.

Results

A total of 671 MSM were included, comprising 460 people with HIV and 211 on pre-exposure prophylaxis. Among them, nine individuals (1.3%) developed skin reactions, with an incidence rate of 1.0 per 100 person-years. Most were fixed drug eruptions (n = 8), with one case of photosensitivity. These reactions typically appeared within 24 h of exposure; and all nine individuals discontinued doxy-PEP, and symptoms resolved within 1–3 weeks. Individuals with a prior history of allergic reactions to any medication were at greater risk of experiencing adverse skin reactions (odds ratio, 6.99; 95% CI, 1.83–26.65). Notably, all individuals who experienced dermatological adverse events had previously used therapeutic doxycycline, though only three reported prior allergic reactions to it.

Conclusions

Although dermatological adverse events associated with doxy-PEP were generally mild, they led to discontinuations. These findings underscore the importance of obtaining a thorough history of drug allergy before initiating doxy-PEP and highlight the need for vigilant monitoring of dermatological adverse events during its use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxycyclineSexually Transmitted DiseasesHomosexuality, MalePost-Exposure ProphylaxisAnti-Bacterial AgentsDrug EruptionsHumansMaleRetrospective StudiesAdultMiddle AgedIncidenceYoung AdultHIV Infections

Substanzen

DoxycyclineAnti-Bacterial Agents

Autor:innen und Institutionen

  • Center for Infection Control, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, 7 Chung-Shan South Road, Taipei, Taiwan.
  • Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
  • Department of Medicine, National Taiwan University Cancer Centre, Taipei, Taiwan.
  • Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan.
  • Department of Tropical Medicine and Parasitology, National Taiwan University College of Medicine, Taipei, Taiwan.

ORCID-Profile: Ling-Ya Chen, Po-Hsien Kuo, Yu-Shan Huang, Kuan-Yin Lin, Chien-Ching Hung

Förderung

  • Taiwan Centers for Disease Control

Zitieren

APA

Chen, L. Y., Lin, W. T., Chen, Y. T., Kuo, P. H., Liu, W. D., Huang, Y. S., Sun, H. Y., Cheng, A., Luo, Y. Z., Wu, P. Y., Chang, H. Y., Lin, K. Y., & Hung, C. C. (2025). Dermatological adverse effects of doxycycline as post-exposure prophylaxis for sexually transmitted infections among men who have sex with men: real-world findings from a multicentre study. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf351

Vancouver

Chen LY, Lin WT, Chen YT, Kuo PH, Liu WD, Huang YS, et al. Dermatological adverse effects of doxycycline as post-exposure prophylaxis for sexually transmitted infections among men who have sex with men: real-world findings from a multicentre study. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf351

BibTeX
@article{Chen2025,
  author = {Chen, Ling-Ya and Lin, Wei-Ting and Chen, Yi-Ting and Kuo, Po-Hsien and Liu, Wang-Da and Huang, Yu-Shan and Sun, Hsin-Yun and Cheng, Aristine and Luo, Yu-Zhen and Wu, Pei-Ying and Chang, Hsi-Yen and Lin, Kuan-Yin and Hung, Chien-Ching},
  title = {Dermatological adverse effects of doxycycline as post-exposure prophylaxis for sexually transmitted infections among men who have sex with men: real-world findings from a multicentre study},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkaf351}
}
Kostenlos starten →